A voyage from 3D to 4D printing in nanomedicine and healthcare: part II.
Gourvi KumariKumar AbhishekSneha SinghAfzal HussainMohammad A AltamimiHarishkumar MadhyasthaThomas Jay WebsterAbhimanyu DevPublished in: Nanomedicine (London, England) (2022)
Recent advancements in biomedical tissue engineering are gaining wide interest. Implementing biology of living cells and organisms using technological solutions such as incorporating 4D printing and bioprinting for tissue regeneration/tissue repair, organ regeneration, early diagnosis of deadly diseases (particularly cancer, cardiac disorders and tuberculosis) has successfully opened a new generation of biomedical research. The present review primarily addresses the clinical application of 4D printing and bioprinting techniques for applications such as early detection of diseases and drug delivery. Notably, this review continues the discussion from part I regarding published informative data, in vitro and in vivo findings, commercial biosensors for early disease diagnosis, drug delivery and current challenges in 4D printing/bioprinting.
Keyphrases
- drug delivery
- living cells
- tissue engineering
- stem cells
- healthcare
- cancer therapy
- fluorescent probe
- papillary thyroid
- single molecule
- mycobacterium tuberculosis
- randomized controlled trial
- left ventricular
- emergency department
- drug release
- squamous cell
- multidrug resistant
- atrial fibrillation
- gram negative
- systematic review
- squamous cell carcinoma
- hiv aids
- pulmonary tuberculosis
- young adults
- health information
- drug induced